Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2005-07-12
2005-07-12
Leffers, Gerry (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S029000, C435S320100, C435S235100, C435S325000, C435S455000, C536S023100
Reexamination Certificate
active
06916635
ABSTRACT:
The invention provides recombinant vectors including adenovirus/adeno-associated virus (Ad/AAV) vectors and mini-adenovirus (mAd) vectors. Further, the invention provides cells containing these vectors, and methods for making and using the vectors and cells. The compositions and methods of the invention are useful in transferring nucleotide sequences of interest into a cell, including, but not limited to, in gene therapy applications.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 5589377 (1996-12-01), Lebkowski et al.
patent: 5691176 (1997-11-01), Lebkowski et al.
patent: 5789390 (1998-08-01), Descamps et al.
patent: 5837484 (1998-11-01), Trempe
patent: 5872005 (1999-02-01), Wang et al.
patent: 5877011 (1999-03-01), Armentano et al.
patent: 5891690 (1999-04-01), Massie
patent: 6040174 (2000-03-01), Imler et al.
patent: 185 573 (1992-05-01), None
patent: WO 88/10311 (1988-12-01), None
patent: WO 90/09441 (1990-08-01), None
patent: WO 91/11525 (1991-08-01), None
patent: WO 91/18088 (1991-11-01), None
patent: WO 99/53085 (1999-10-01), None
Gnatenko, et al. Blood, Nov. 15, 1999, vol. 94, No. 10 SUPPL. Part 1, p. 181a. Meeting Info: Forty-first Annual Meeting of the American Society of Hematology. New Orleans, Lousiana, USA, Dec. 3-7, 1999.
Benihoud et al. (1999) “Adenovirus vectors for gene delivery,” Curr. Opin. Biotechnol. 10:440-7.
Brenner (1999) “Gene Transfer by Adenovectors,” Blood 94:3965-7.
Kochanek (1999) “High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy,” Hum. Gene. Ther. 10:2451-9.
Wold (1999) “Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic,” Human Press, Totowa, NJ.
Tripathy et al. (1996) “Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors,” Nat. Med. 2:545-50.
Yang et al. (1996) “Role of Viral Antigens in Destructive Cellular Immune Responses to Adenovirus Vector-Transduced Cells in Mouse Lung,” J. Virol. 70:7209-12.
Thrasher et al. (1995) “Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase,” Gene Ther. 2:481-485.
Fisher et al. (1996) “A Novel Adenovirus-Adeno-Associated Virus Hybrid Vector That Displays Efficient Rescue and Delivery of the AAV Genome,” Human Gene Ther. 7:2079-2087.
Lieber et al. (1999) “Integrating Adenovirus-Adeno-Associated Virus Vectors Devoid of All Viral Genes,” J. Virol. 73:9314-9324.
Liu et al. (1999) “Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus,”Gene Ther. 6:293-299.
Berns et al. (1995) “Adenovirus and Adeno-Associated Virus as Vectors for Gene Therapy,” Ann. NY Acad. Sci. 772:95-104.
Muzyczka (1992) “Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells,” Curr. Top. Microbiol. Immunol. 158:97-129.
Rolling and Samulski (1995) Mol. Biotechnol. 3:9-15.
Bett et al. (1993) “Packaging Capacity and Stability of Human Adenovirus Type 5 Vectors,” J. Virol. 67:5911-21.
Parks and Graham (1997) “A Helper-Dependent System for Adenovirus Vector Production Helps Define a Lower Limit for Efficient DNA Packaging,” J. Virol. 71:3293-8.
Akli et al. (1993) “Transfer of a foreign gene into the brain using adenovirus vectors,” Nature Genetics 3:224.
Stratford-Perricaudet et al. (1990) “Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus Vector,” Human Gene Ther. 1:241.
Levrero et al. (1991) “Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo,” Gene 101:195.
Le Gal la Salle et al. (1993) “An Adenovirus Vector for Gene Transfer into Neurons and Glia in the Brain,” Science 259:988.
Roemer and Friedmann (1992) “Concepts and strategies for human gene therapy,” Eur. J. Biochem. 208:211.
Dobson et al. (1990) “A Latent, Nonpathogenic HSV-1-Derived Vector Stably Expresses β-Galactosidase in Mouse Neurons,” Neuron 5:353.
Chiocca et al. (1990) “Transfer and Expression of thelacZGene in Rat Brain Neurons Mediated by Herpes Simplex Virus Mutants,” New Biol. 2:739.
Miyanohara et al. (1992) “Direct Gene Transfer to the Liver with Herpes Simplex Virus Type 1 Vectors,” Transient Production of Physiologically Relevant Levels of Circulating Factor IX, New Biol. 4:238.
Xiao et al. (1997) “A Novel 165-Base-Pair Terminal Repeat Sequence Is the SolecisRequirement for the Adeno-Associated Virus Life Cycle,” J. Virol. 71:941-948.
Ryan et al. (1996) “Sequence Requirements for Binding of Rep68 to the Adeno-Associated Virus Terminal Repeats,” J. Virol. 70:1542-1553.
Imler et al. (1996) “Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E-1 deleted adenovirus vectors,” Gene Ther. 3:75-84.
Fallaux et al. (1998) “New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses,” Human Gene Ther. 9:1909-1917.
Fallaux et al. (1996) “Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors,” Human Gene Ther. 7:215-222.
Weinberg et al. (1983) “A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2,” Proc. Natl. Acad. Sci. USA 80:5383-5386.
Brough et al. (1996) “A Gene Transfer Vector-Cell Line System for Complete Functional Complementation of Adenovirus Early Regions E1 and E4,” J. Virol. 70:6497-501.
Hearing et al. (1987) “Identification of a Repeated Sequence Element Required for Efficient Encapsidation of the Adenovirus Type 5 Chromosome,” J. Virol. 61:2555-8.
Zolotukhin et al. (1996) “A Humanized Green Fluorescent Protein cDNA Adapted for High-Level Expression in Mammalian Cells,” J. Virol. 70:4646-54.
Stow (1981) “Cloning of a DNA Fragment from the Left-Hand Terminus of the Adenovirus Type 2 Genome and Its Use in Site-Directed Mutagenesis,” J. Virol. 37:171-180.
Graham et al. (1977) “Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,” J. Gen. Virol. 36:59-74.
Thimmappaya et al. (1982) “Adenovirus VAI RNA Is Required for Efficient Translation of Viral mRNAs at Late Times after Infection,” Cell, Dec. 31 (3 Pt 2): 543-551.
Tollefson et al. (1996) “The Adenovirus Death Protein (E3-11.6K) Is Required at Very Late Stages of Infection for Efficient Cell Lysis and Release of Adenovirus from Infected Cells,” J. Virol. 70(4):2296-2306.
Steinwaerder et al. (1999) “Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination between Inverted Repeats,” J. Virol. 73:9303-13.
Clark et al. (1996) “A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors,” Gene Ther. 3:1124-32.
Hirt (1967) “Selective Extraction of Polyoma DNA from Infected Mouse Cell Cultures,” J. Mol. Biol. 26:365-9.
Nevins (1981) “Mechanism of Activation of Early Viral Transcription by the Adenovirus E1A Gene Product,” Cell 26:213-20.
Sandalon et al. (1997) “In VitroAssembly of SV40 Virions and Pseudovirions: Vector Development for Gene Therapy,” Hum. Gene Ther. 8:843-9.
Gnatenko et al. (1999) “An Adenovirus/Adeno-associated Hybrid Virus Generates a Mini-Adenovirus Devoid of all Viral Genes,” Blood (supplement) 94:181a, Abstract No. 788.
Molin et al. (1998) “Two Novel Adenovirus Vector Systems Permitting
Bahou Wadie F.
Gnatenko Dmitri V.
Hearing Patrick
Sandalon Ziv
Leffers Gerry
Medlen & Carroll LLP
The Research Foundation of State University of New York
LandOfFree
Hybrid adenovirus/adeno-associated virus vectors and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid adenovirus/adeno-associated virus vectors and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid adenovirus/adeno-associated virus vectors and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3417945